A new approach to personalized drug treatment emerges in a study examining the metabolic profile of rats. The profile, which is a measurement of small molecules such as sugars and amino acids, is used to predict the response to drugs that are toxic to the liver. This study proposes the extension of this concept into humans as a way of predicting the outcome of a therapy for a given profile.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
FDA Consum. 36 (2005).
Clayton, T.A. et al. Nature, 440, 1073–1077 (2006).
Lenz, E.M. et al. J. Pharm. Biomed. Anal. 36, 841–849 (2004).
Bijlsma, S. et al. Anal. Chem. 78, 567–574 (2006).
Chambers, J., Lim, E., Jain, P., Singh, D., Elliott, P. & Kooner, J. Heart 92 Suppl 2, A4–A121 (2006).
Chambers, J., Lim, E., Singh, D., Jain, P., Elliott, P. & Kooner, J. Heart 92 Suppl 2, A4–A121 (2006).
Lim, E., Lightstone, L., Chambers, J., Roderick, P., Mullee, M. & Kooner, J. Heart 92 Suppl 2, A4–A121 (2006).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Haselden, J., Nicholls, A. Personalized medicine progresses. Nat Med 12, 510–511 (2006). https://doi.org/10.1038/nm0506-510
Issue Date:
DOI: https://doi.org/10.1038/nm0506-510
This article is cited by
-
Personalized medicine and quantitative trait transcripts
Nature Genetics (2007)
-
Moderne Methoden in der Genomforschung und Humangenetik
Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz (2006)
